Pulmonary regurgitation after repaired tetralogy of Fallot: surgical versus percutaneous treatment
Author(s) -
Juan Antonio Meca Aguirrezabalaga,
Jacobo Silva Guisasola,
Rocío Díaz Méndez,
Alain Eliott Escalera Veizaga,
Daniel Hernández-Vaquero Panizo
Publication year - 2020
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2020.03.81
Subject(s) - tetralogy of fallot , medicine , pulmonary regurgitation , pulmonary valve insufficiency , pulmonary valve , regurgitation (circulation) , gold standard (test) , percutaneous , ventricle , cardiology , surgery , valve replacement , stenosis , heart disease
Pulmonary regurgitation is the most important sequellae after correction of Tetralogy of Fallot and has a considerable impact over the right ventricle. Surgery has demonstrated low early mortality after pulmonary valve replacement and good long-term outcomes, remaining nowadays the gold standard treatment of pulmonary regurgitation in rTOF patients. Nevertheless, transcatheter pulmonary valve implantation has emerged as a new, safe and efficient alternative to surgical valve replacement. In this review article, we try to evaluate and compare both techniques to find out which is the best therapeutic option in this patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom